144 related articles for article (PubMed ID: 30857932)
1. Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
Sekiya T; Mifsud EJ; Ohno M; Nomura N; Sasada M; Fujikura D; Daito T; Shingai M; Ohara Y; Nishimura T; Endo M; Mitsumata R; Ikeda T; Hatanaka H; Kitayama H; Motokawa K; Sobue T; Suzuki S; Itoh Y; Brown LE; Ogasawara K; Kino Y; Kida H
Vaccine; 2019 Apr; 37(15):2158-2166. PubMed ID: 30857932
[TBL] [Abstract][Full Text] [Related]
2. Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
Shingai M; Nomura N; Sekiya T; Ohno M; Fujikura D; Handabile C; Omori R; Ohara Y; Nishimura T; Endo M; Kimachi K; Mitsumata R; Ikeda T; Kitayama H; Hatanaka H; Sobue T; Muro F; Suzuki S; Thanh Nguyen C; Ishigaki H; Nakayama M; Mori Y; Itoh Y; Koutsakos M; Chua BY; Kedzierska K; Brown LE; Jackson DC; Ogasawara K; Kino Y; Kida H
Vaccine; 2021 Jun; 39(29):3940-3951. PubMed ID: 34090697
[TBL] [Abstract][Full Text] [Related]
3. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
[TBL] [Abstract][Full Text] [Related]
4. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
5. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
[TBL] [Abstract][Full Text] [Related]
6. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
[TBL] [Abstract][Full Text] [Related]
7. Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques.
Chua BY; Sekiya T; Koutsakos M; Nomura N; Rowntree LC; Nguyen THO; McQuilten HA; Ohno M; Ohara Y; Nishimura T; Endo M; Itoh Y; Habel JR; Selva KJ; Wheatley AK; Wines BD; Hogarth PM; Kent SJ; Chung AW; Jackson DC; Brown LE; Shingai M; Kedzierska K; Kida H
PLoS Pathog; 2022 Oct; 18(10):e1010891. PubMed ID: 36206307
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of A/H1N1/2009 split inactivated influenza A vaccine (GC1115) in mice and ferrets.
Han HJ; Song MS; Park SJ; Byun HY; Robles NJC; Ha SH; Choi YK
J Microbiol; 2019 Feb; 57(2):163-169. PubMed ID: 30706345
[TBL] [Abstract][Full Text] [Related]
9. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine.
Handabile C; Ohno M; Sekiya T; Nomura N; Kawakita T; Kawahara M; Endo M; Nishimura T; Okumura M; Toba S; Sasaki M; Orba Y; Chua BY; Rowntree LC; Nguyen THO; Shingai M; Sato A; Sawa H; Ogasawara K; Kedzierska K; Kida H
Sci Rep; 2024 Feb; 14(1):4204. PubMed ID: 38378856
[TBL] [Abstract][Full Text] [Related]
11. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
12. Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice.
Nakatsukasa A; Kuruma K; Okamatsu M; Hiono T; Suzuki M; Matsuno K; Kida H; Oyamada T; Sakoda Y
Vaccine; 2017 May; 35(21):2855-2861. PubMed ID: 28431812
[TBL] [Abstract][Full Text] [Related]
13. Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.
Dong W; Bhide Y; Sicca F; Meijerhof T; Guilfoyle K; Engelhardt OG; Boon L; de Haan CAM; Carnell G; Temperton N; de Vries-Idema J; Kelvin D; Huckriede A
Front Immunol; 2018; 9():2312. PubMed ID: 30356772
[TBL] [Abstract][Full Text] [Related]
14. Memory immune responses against pandemic (H1N1) 2009 influenza virus induced by a whole particle vaccine in cynomolgus monkeys carrying Mafa-A1*052:02.
Arikata M; Itoh Y; Okamatsu M; Maeda T; Shiina T; Tanaka K; Suzuki S; Nakayama M; Sakoda Y; Ishigaki H; Takada A; Ishida H; Soda K; Pham VL; Tsuchiya H; Nakamura S; Torii R; Shimizu T; Inoko H; Ohkubo I; Kida H; Ogasawara K
PLoS One; 2012; 7(5):e37220. PubMed ID: 22623997
[TBL] [Abstract][Full Text] [Related]
15. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.
Quan FS; Huang C; Compans RW; Kang SM
J Virol; 2007 Apr; 81(7):3514-24. PubMed ID: 17251294
[TBL] [Abstract][Full Text] [Related]
16. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
[TBL] [Abstract][Full Text] [Related]
17. M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice.
Sarawar S; Hatta Y; Watanabe S; Dias P; Neumann G; Kawaoka Y; Bilsel P
Vaccine; 2016 Sep; 34(42):5090-5098. PubMed ID: 27595896
[TBL] [Abstract][Full Text] [Related]
18. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
[TBL] [Abstract][Full Text] [Related]
19. Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.
Shiohara M; Suzuki S; Shichinohe S; Ishigaki H; Nakayama M; Nomura N; Shingai M; Sekiya T; Ohno M; Iida S; Kawai N; Kawahara M; Yamagishi J; Ito K; Mitsumata R; Ikeda T; Motokawa K; Sobue T; Kida H; Ogasawara K; Itoh Y
Vaccine; 2022 Jun; 40(30):4026-4037. PubMed ID: 35641357
[TBL] [Abstract][Full Text] [Related]
20. Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.
Morgan SB; Hemmink JD; Porter E; Harley R; Shelton H; Aramouni M; Everett HE; Brookes SM; Bailey M; Townsend AM; Charleston B; Tchilian E
J Immunol; 2016 Jun; 196(12):5014-23. PubMed ID: 27183611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]